{"id":"W4417001881","doi":"10.1182/blood-2025-100","title":"Safety and efficacy of elranatamab in combination with iberdomide in patients with relapsed or refractory multiple myeloma: Results from the phase 1b MagnetisMM-30 trial","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"Dr. Everett Chalmers Regional Hospital; Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Refractory (planetary science); Regimen; Multiple myeloma; Phases of clinical research; Bone marrow; Neutropenia; Bortezomib; Lenalidomide; Proteasome inhibitor; Progressive disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002107421,0.001031259,0.00199097,0.0002909198,0.0002857151,0.0009881877,0.0006671548,0.0008657645,0.001577349],"category_scores_gemma":[0.0008812866,0.0003323371,0.001445021,0.0003846317,0.0004918036,0.0005716129,0.0003897926,0.001883636,0.0005189207],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009245459,"about_ca_system_score_gemma":0.0009380137,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006351225,"about_ca_topic_score_gemma":0.00152518,"domain_scores_codex":[0.9993644,0.0003444367,0.00004495955,0.0001043291,0.00005881501,0.00008305161],"domain_scores_gemma":[0.9994063,0.00009533072,0.0001724377,0.00003790566,0.00002861365,0.000259431],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7742067,0.01770188,0.0258353,0.001394782,0.00442803,0.0003200011,0.0001932682,0.002774774,0.03358992,0.0002837162,0.006936476,0.1323351],"study_design_scores_gemma":[0.6614764,0.2442138,0.0765989,0.0001406597,0.002850484,0.0006435668,0.00007731729,0.002912194,0.003814908,0.0005626759,0.006644488,0.00006454917],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9856966,0.009773309,0.0002847163,0.0006956716,0.000110655,0.0006250198,0.001168648,0.00007207858,0.001573241],"genre_scores_gemma":[0.9917286,0.002685212,0.0006383737,0.0009764662,0.0002153627,0.0006478579,0.002186622,0.00001943691,0.0009020572],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002107421,"threshold_uncertainty_score":0.01114529,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01264038927877809,"score_gpt":0.275946361885988,"score_spread":0.2633059726072099,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}